AbbVie Inc. (ABBV) fundamentals from SEC filings — revenue $61.2B, net margin 6.9%, diluted EPS $2.36 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $56.2B | $58.1B | $54.3B | $56.3B | $61.2B |
| Net income | $11.5B | $11.8B | $4.9B | $4.3B | $4.2B |
| Net margin | 20.5% | 20.4% | 8.9% | 7.6% | 6.9% |
| Diluted EPS | $6.45 | $6.63 | $2.72 | $2.39 | $2.36 |
| Free cash flow | $22.0B | $24.2B | $22.1B | $17.8B | $17.8B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home